Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy with immunoglobulins].

E Müller1, P Zabel

  • 1Forschungsinstitut Borstel, Medizinische Klinik.

Immunitat Und Infektion
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Intravenous immunoglobulin (IVIG) therapy is a revolutionary treatment for humoral immunodeficiencies and autoimmune diseases like idiopathic thrombocytopenic purpura. Current treatment for subclass deficiencies is limited to patients experiencing recurrent infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pvB370 BamHI satellite DNA family of the Drosophila virilis group and its evolutionary relation to mobile dispersed genetic pDv elements.

Journal of molecular evolution·1995
Same author

The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis.

Circulation·1995
Same author

Factors influencing flow-induced signal loss in MR angiography: an in vitro study.

Journal of computer assisted tomography·1995
Same author

Rapid adaptation to eccentric exercise-induced muscle damage.

International journal of sports medicine·1995
Same author

Allergic contact dermatitis from minoxidil.

Contact dermatitis·1995
Same author

Frequency of common cystic fibrosis gene mutations in chronic bronchitis patients.

Scandinavian journal of clinical and laboratory investigation·1995
Same journal

[Cat scratch disease caused by Bartonella henselae].

Immunitat und Infektion·1995
Same journal

[Gas gangrene as a manifestation of endogenous Clostridium septicum infection].

Immunitat und Infektion·1995
Same journal

[Actinomycetes canaliculitis--case reports].

Immunitat und Infektion·1995
Same journal

[Leprosy--current aspects of a disease from biblical times].

Immunitat und Infektion·1995
Same journal

[Rational use of antimycotics against yeast infections].

Immunitat und Infektion·1995
Same journal

[Antimicrobial oligopeptides--an important factor in non-specific defense against infection].

Immunitat und Infektion·1995
See all related articles

Area of Science:

  • Immunology
  • Hematology
  • Autoimmune Diseases

Context:

  • Humoral immunodeficiencies significantly impact patient outcomes.
  • Intravenous immunoglobulin (IVIG) therapy has transformed treatment paradigms.
  • Idiopathic thrombocytopenic purpura (ITP) is a key autoimmune condition addressed by IVIG.

Purpose:

  • To review the established role of IgG-replacement therapy in humoral immunodeficiencies.
  • To explore the proposed mechanisms of IVIG action in autoimmune diseases, focusing on ITP.
  • To discuss the current limitations in treating immunoglobulin subclass deficiencies.

Summary:

  • IgG-replacement therapy, particularly IVIG, is the standard treatment for humoral immunodeficiencies, greatly improving patient prognosis.
  • IVIG's therapeutic effects in autoimmune conditions like ITP are attributed to Fc-receptor blockade and immunomodulatory actions.

Related Experiment Videos

  • Treatment for immunoglobulin subclass deficiencies remains restricted to individuals with recurrent infections.

    • Impact:

    • IVIG therapy has revolutionized the management of primary immunodeficiency disorders.
    • Understanding IVIG's mechanisms offers insights into treating various autoimmune and immune-mediated conditions.
    • Further research is needed to expand treatment options for immunoglobulin subclass deficiencies beyond infection prevention.